24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer’s Disease: Analyses from a Clinical Trial with Nabilone

BACKGROUND: Agitation is a prevalent and difficult-to-treat symptom of Alzheimer’s disease (AD). The endocannabinoid system (ECS) has been a target of interest for the treatment of agitation. However, ECS signaling may interact with AD-related changes in brain cholesterol metabolism. Elevated brain...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruthirakuhan, Myuri, Herrmann, Nathan, Andreazza, Ana C., Verhoeff, Nicolaas Paul L.G., Gallagher, Damien, Black, Sandra E., Kiss, Alex, Lanctôt, Krista L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839471/
https://www.ncbi.nlm.nih.gov/pubmed/31322567
http://dx.doi.org/10.3233/JAD-190202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839471/
https://www.ncbi.nlm.nih.gov/pubmed/31322567
http://dx.doi.org/10.3233/JAD-190202

Ejemplares similares